Innate Pharma historical data
| Date | Open | High | Low | Close | Adj. close | Volume |
|---|---|---|---|---|---|---|
| 2025-02-25 | 2.380 | 2.420 | 2.150 | 2.160 | 2.160 | 450,620 |
| 2025-02-24 | 2.195 | 2.285 | 2.145 | 2.270 | 2.270 | 286,859 |
| 2025-02-21 | 2.085 | 2.205 | 2.070 | 2.200 | 2.200 | 257,282 |
| 2025-02-20 | 2.150 | 2.150 | 2.055 | 2.100 | 2.100 | 181,918 |
| 2025-02-19 | 2.175 | 2.205 | 2.025 | 2.155 | 2.155 | 407,899 |
| 2025-02-18 | 2.115 | 2.500 | 2.060 | 2.125 | 2.125 | 1,502,491 |
| 2025-02-17 | 2.025 | 2.090 | 1.972 | 2.090 | 2.090 | 395,571 |
| 2025-02-14 | 1.916 | 1.968 | 1.916 | 1.924 | 1.924 | 79,108 |
| 2025-02-13 | 1.900 | 1.930 | 1.900 | 1.916 | 1.916 | 42,317 |
| 2025-02-12 | 1.916 | 1.948 | 1.870 | 1.900 | 1.900 | 108,282 |
| 2025-02-11 | 1.950 | 1.950 | 1.910 | 1.924 | 1.924 | 45,676 |
| 2025-02-10 | 1.958 | 1.958 | 1.812 | 1.944 | 1.944 | 156,827 |
| 2025-02-07 | 1.982 | 2.005 | 1.940 | 1.958 | 1.958 | 86,424 |
| 2025-02-06 | 1.970 | 2.040 | 1.950 | 2.010 | 2.010 | 203,334 |
| 2025-02-05 | 1.958 | 1.988 | 1.902 | 1.932 | 1.932 | 173,812 |
| 2025-02-04 | 1.768 | 2.050 | 1.754 | 1.952 | 1.952 | 370,548 |
| 2025-02-03 | 1.790 | 1.800 | 1.740 | 1.766 | 1.766 | 73,104 |
| 2025-01-31 | 1.730 | 1.820 | 1.730 | 1.800 | 1.800 | 90,829 |
| 2025-01-30 | 1.730 | 1.748 | 1.714 | 1.746 | 1.746 | 47,037 |
| 2025-01-29 | 1.736 | 1.748 | 1.716 | 1.716 | 1.716 | 27,029 |
| 2025-01-28 | 1.720 | 1.740 | 1.710 | 1.734 | 1.734 | 67,358 |
| 2025-01-27 | 1.710 | 1.880 | 1.710 | 1.752 | 1.752 | 290,150 |
| 2025-01-24 | 1.724 | 1.728 | 1.702 | 1.708 | 1.708 | 38,761 |
| 2025-01-23 | 1.712 | 1.722 | 1.702 | 1.712 | 1.712 | 60,210 |
| 2025-01-22 | 1.750 | 1.788 | 1.740 | 1.744 | 1.744 | 43,948 |
| 2025-01-21 | 1.708 | 1.750 | 1.704 | 1.750 | 1.750 | 27,900 |
| 2025-01-20 | 1.730 | 1.770 | 1.708 | 1.726 | 1.726 | 63,088 |
| 2025-01-17 | 1.748 | 1.756 | 1.726 | 1.732 | 1.732 | 63,177 |
| 2025-01-16 | 1.736 | 1.764 | 1.736 | 1.740 | 1.740 | 83,806 |
| 2025-01-15 | 1.840 | 1.840 | 1.730 | 1.770 | 1.770 | 134,251 |
| 2025-01-14 | 1.806 | 1.838 | 1.804 | 1.822 | 1.822 | 54,682 |
| 2025-01-13 | 1.810 | 1.850 | 1.800 | 1.842 | 1.842 | 95,996 |
| 2025-01-10 | 1.866 | 2.020 | 1.770 | 1.808 | 1.808 | 443,957 |
| 2025-01-09 | 1.822 | 1.822 | 1.762 | 1.770 | 1.770 | 59,589 |
| 2025-01-08 | 1.850 | 1.866 | 1.820 | 1.822 | 1.822 | 40,878 |
| 2025-01-07 | 1.870 | 1.878 | 1.842 | 1.850 | 1.850 | 56,208 |
| 2025-01-06 | 1.920 | 1.926 | 1.860 | 1.870 | 1.870 | 109,724 |
| 2025-01-03 | 1.880 | 1.928 | 1.880 | 1.912 | 1.912 | 20,835 |
| 2025-01-02 | 1.900 | 1.900 | 1.862 | 1.890 | 1.890 | 74,921 |
| 2024-12-31 | 1.920 | 1.954 | 1.910 | 1.932 | 1.932 | 30,238 |
| 2024-12-30 | 1.958 | 1.958 | 1.920 | 1.938 | 1.938 | 33,687 |
| 2024-12-27 | 1.950 | 1.960 | 1.910 | 1.950 | 1.950 | 95,444 |
| 2024-12-24 | 1.950 | 1.950 | 1.914 | 1.920 | 1.920 | 36,430 |
| 2024-12-23 | 1.920 | 2.030 | 1.920 | 1.934 | 1.934 | 88,949 |
| 2024-12-20 | 2.000 | 2.000 | 1.900 | 1.924 | 1.924 | 112,636 |
| 2024-12-19 | 1.920 | 2.085 | 1.906 | 2.010 | 2.010 | 131,269 |
| 2024-12-18 | 2.000 | 2.000 | 1.940 | 1.976 | 1.976 | 202,139 |
| 2024-12-17 | 2.110 | 2.110 | 1.940 | 2.045 | 2.045 | 374,258 |
| 2024-12-16 | 2.380 | 2.490 | 2.140 | 2.140 | 2.140 | 1,288,712 |
| 2024-12-13 | 1.532 | 1.900 | 1.390 | 1.900 | 1.900 | 579,444 |
| 2024-12-12 | 1.628 | 1.628 | 1.550 | 1.550 | 1.550 | 114,302 |
| 2024-12-11 | 1.750 | 1.750 | 1.576 | 1.600 | 1.600 | 149,831 |
| 2024-12-10 | 1.796 | 1.826 | 1.624 | 1.694 | 1.694 | 473,591 |
| 2024-12-09 | 1.530 | 1.890 | 1.500 | 1.662 | 1.662 | 1,069,166 |
| 2024-12-06 | 1.420 | 1.518 | 1.404 | 1.482 | 1.482 | 279,325 |
| 2024-12-05 | 1.402 | 1.430 | 1.360 | 1.362 | 1.362 | 75,115 |
| 2024-12-04 | 1.364 | 1.428 | 1.360 | 1.426 | 1.426 | 65,243 |
| 2024-12-03 | 1.350 | 1.378 | 1.350 | 1.374 | 1.374 | 28,231 |
| 2024-12-02 | 1.470 | 1.470 | 1.332 | 1.366 | 1.366 | 162,373 |
| 2024-11-29 | 1.416 | 1.438 | 1.408 | 1.424 | 1.424 | 39,859 |
Stock splits
No stock splits on record.
Dividends
No dividends on record.
Open, high, low and close are as traded (EUR). Adjusted close accounts for splits and dividends. Educational only, not financial advice.